Cardio Diagnostics (CDIO) Competitors $0.97 -0.05 (-4.90%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CDIO vs. DRUG, CRBP, IPHA, SGMT, ACTU, STRO, CRBU, TSVT, HURA, and NKTXShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Bright Minds Biosciences (DRUG), Corbus Pharmaceuticals (CRBP), Innate Pharma (IPHA), Sagimet Biosciences (SGMT), Actuate Therapeutics (ACTU), Sutro Biopharma (STRO), Caribou Biosciences (CRBU), 2seventy bio (TSVT), TuHURA Biosciences (HURA), and Nkarta (NKTX). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Bright Minds Biosciences Corbus Pharmaceuticals Innate Pharma Sagimet Biosciences Actuate Therapeutics Sutro Biopharma Caribou Biosciences 2seventy bio TuHURA Biosciences Nkarta Bright Minds Biosciences (NASDAQ:DRUG) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations. Which has more risk and volatility, DRUG or CDIO? Bright Minds Biosciences has a beta of -7.06, indicating that its stock price is 806% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 4.59, indicating that its stock price is 359% more volatile than the S&P 500. Does the media favor DRUG or CDIO? In the previous week, Cardio Diagnostics had 2 more articles in the media than Bright Minds Biosciences. MarketBeat recorded 3 mentions for Cardio Diagnostics and 1 mentions for Bright Minds Biosciences. Cardio Diagnostics' average media sentiment score of 0.84 beat Bright Minds Biosciences' score of 0.67 indicating that Cardio Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bright Minds Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardio Diagnostics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor DRUG or CDIO? Cardio Diagnostics received 2 more outperform votes than Bright Minds Biosciences when rated by MarketBeat users. However, 100.00% of users gave Bright Minds Biosciences an outperform vote while only 80.00% of users gave Cardio Diagnostics an outperform vote. CompanyUnderperformOutperformBright Minds BiosciencesOutperform Votes2100.00% Underperform VotesNo VotesCardio DiagnosticsOutperform Votes480.00% Underperform Votes120.00% Do analysts rate DRUG or CDIO? Bright Minds Biosciences presently has a consensus price target of $75.00, suggesting a potential upside of 94.05%. Cardio Diagnostics has a consensus price target of $2.00, suggesting a potential upside of 106.19%. Given Cardio Diagnostics' higher possible upside, analysts clearly believe Cardio Diagnostics is more favorable than Bright Minds Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, DRUG or CDIO? Bright Minds Biosciences has higher earnings, but lower revenue than Cardio Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright Minds BiosciencesN/AN/A-$5.47M-$0.68-56.84Cardio Diagnostics$35.69K1,099.16-$8.38MN/AN/A Is DRUG or CDIO more profitable? Bright Minds Biosciences has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -22,777.20%. Bright Minds Biosciences' return on equity of -58.55% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Bright Minds BiosciencesN/A -58.55% -53.79% Cardio Diagnostics -22,777.20%-258.85%-191.20% Do institutionals and insiders hold more shares of DRUG or CDIO? 40.5% of Bright Minds Biosciences shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 42.7% of Bright Minds Biosciences shares are owned by company insiders. Comparatively, 22.3% of Cardio Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryBright Minds Biosciences beats Cardio Diagnostics on 9 of the 15 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.23M$2.51B$5.13B$9.08BDividend YieldN/A0.73%4.93%4.22%P/E RatioN/A6.0789.6617.18Price / Sales1,099.1675.121,115.28116.98Price / CashN/A15.0542.8237.86Price / Book6.933.284.794.78Net Income-$8.38M$29.98M$120.04M$225.60M7 Day Performance-23.02%-1.55%-1.91%-1.23%1 Month Performance292.08%8.21%11.48%3.36%1 Year Performance-58.01%-21.46%30.60%16.60% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics2.6566 of 5 stars$0.97-4.9%$2.00+106.2%-55.7%$39.23M$35,688.000.007Gap UpDRUGBright Minds Biosciences3.5821 of 5 stars$40.82-0.4%$75.00+83.7%+2,621.8%$181.00MN/A-60.29N/ANews CoverageCRBPCorbus Pharmaceuticals3.8075 of 5 stars$14.52-3.7%$62.00+327.0%+147.6%$176.85M$880,000.00-3.2240IPHAInnate Pharma2.7537 of 5 stars$2.18-27.8%$11.50+427.2%-23.5%$176.63M$24.85M0.00220News CoverageGap DownHigh Trading VolumeSGMTSagimet Biosciences2.3237 of 5 stars$5.69+29.6%$23.00+304.2%-8.0%$174.51M$2M0.008Gap UpHigh Trading VolumeACTUActuate TherapeuticsN/A$8.85+2.7%N/AN/A$172.86MN/A0.0010Gap UpSTROSutro Biopharma4.4638 of 5 stars$2.09-1.4%$11.13+432.3%-51.3%$172.34M$153.73M-1.32240CRBUCaribou Biosciences2.2043 of 5 stars$1.89-1.3%$10.20+441.1%-69.4%$170.69M$11.48M-1.16100Positive NewsTSVT2seventy bio2.2124 of 5 stars$3.30+0.9%$9.00+172.7%-7.1%$170.25M$100.39M-1.76440Positive NewsHURATuHURA BiosciencesN/A$4.01-18.7%$15.00+274.1%N/A$169.56MN/A0.00N/AAnalyst ForecastNews CoverageNKTXNkarta2.7945 of 5 stars$2.34flat$15.00+541.0%-35.4%$165.13MN/A-1.24140Gap Up Related Companies and Tools Related Companies DRUG Competitors CRBP Competitors IPHA Competitors SGMT Competitors ACTU Competitors STRO Competitors CRBU Competitors TSVT Competitors HURA Competitors NKTX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDIO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDIO Stock Alerts